The Pulmonary Fibrosis Foundation (PFF)Â has launched its Oxygen Information Line to provide information and resources to help people using…
Articles by Janet Stewart, MSc
Scientists found that a special kind of white blood cell could potentially be stimulated to migrate to the lungs of…
The rate of decline in lung function in patients with idiopathic pulmonary fibrosis (IPF) before they are treated with…
Boehringer Ingelheim‘s Ofev (nintedanib) preserved the lung function of nine idiopathic  pulmonary fibrosis patients waiting for a lung transplant,…
A lung transplant can benefit those whose pulmonary fibrosis (PF) stems from Hermansky-Pudlak syndrome (HPS), a study indicate. The study,…
PMD Healthcare is creating advisory boards composed of pulmonary fibrosis and cystic fibrosis patients and caregivers. The company, whose…
The Pulmonary Fibrosis Foundation plans to expand its U.S. Care Center Network from the existing 45 facilities, which provide…
The U.S. Food and Drug Administration has granted orphan drug status to Prometic Life Sciences’ Ryplazim (plasminogen) as a…
The American Thoracic Society and Boehringer Ingelheim have established a two-year, $100,000 fellowship for idiopathic pulmonary fibrosis research. Pulmonary fibrosis is…
Boehringer Ingelheim has extended its collaboration with Inventiva on developing treatments for tissue-scarring conditions such as idiopathic pulmonary fibrosis, or IPF.